Prostatype Genomics OCF Margin

Operating Cash Flow Margin of Prostatype Genomics is -22,466.83 % in 2026.

Operating Cash Flow Margin of Prostatype Genomics changed from -2,148.82 % to -22,466.83 %, representing a 945.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Prostatype Genomics since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Prostatype Genomics with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.